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Infection with Helicobacter pylori increases the risk for 
peptic ulcer disease (PUD) and its complications. To deter-
mine whether hospitalization rates for PUD have declined 
since antimicrobial drugs to eradicate H. pylori became avail-
able, we examined 1998–2005 hospitalization records (us-
ing the Nationwide Inpatient Sample) in which the primary 
discharge diagnosis was PUD. Hospitalizations for which the 
diagnosis was H. pylori infection were also considered. The 
age-adjusted hospitalization rate for PUD decreased 21% 
from 71.1/100,000 population (95% conﬁ  dence interval [CI] 
68.9–73.4) in 1998 to 56.5/100,000 in 2005 (95% CI 54.6–
58.3). The hospitalization rate for PUD was highest for adults 
>65 years of age and was higher for men than for women. 
The age-adjusted rate was lowest for whites and declined for 
all racial/ethnic groups, except Hispanics. The age-adjusted 
H. pylori hospitalization rate also decreased. The decrease 
in PUD hospitalization rates suggests that the incidence of 
complications caused by H. pylori infection has declined.
P
eptic ulcer disease (PUD) is a common illness that af-
fects >6 million persons in the United States each year, 
causing considerable illness and a large economic cost to 
the healthcare system (1). Infection with Helicobacter py-
lori substantially increases the risk for PUD and its com-
plications (2). Appropriate antimicrobial drug regimens to 
eradicate the infection and cure ulcers have been available 
since Marshall and Warren discovered H. pylori as an eti-
ologic agent of ulcers in the early 1980s (3). Eradicating 
these infections prevents recurrence and ulcer complica-
tions such as bleeding or perforation (4–6). Therefore, a 
decline in hospitalizations for PUD and its complications 
could be expected since treatment for H. pylori infection 
became available.
Although rates of hospitalization for PUD declined 
in the United States during the 1980s and 1990s, rates re-
mained high (7,8). One reason was the lack of knowledge 
among the general public and clinicians about the link be-
tween H. pylori and PUD (9–11). The Centers for Disease 
Control and Prevention, in collaboration with partners from 
other federal agencies, academic institutions, and private 
industry, initiated an educational campaign in 1997 to in-
crease awareness of the relationship (9). The goals of the 
campaign were to promote the increased use of appropriate 
antimicrobial drug treatment to eradicate H. pylori, which 
would thus lead to a further decline in rates of hospitaliza-
tion for PUD and its complications. Accordingly, reducing 
hospitalizations for PUD 35% from the 1998 baseline rate 
of 71/100,000 population to 46/100,000 population by the 
year 2010 was included in the Healthy People 2010 objec-
tives that were developed in 1998 by the US Department of 
Health and Human Services (12).
The prevalence of H. pylori infections and their as-
sociated conditions can vary considerably among popu-
lation groups within the same country. Racial and ethnic 
differences have been noted, with blacks more affected 
than whites and Mexican-Americans more affected than 
non-Hispanic whites and non-Hispanic blacks (12,13). A 
recent meta-analysis in which researchers adjusted for age 
and socioeconomic status, showed that H. pylori infection 
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was signiﬁ  cantly associated with male sex in 18 adult pop-
ulations (14). In addition, male patients were hospitalized 
more often for duodenal ulcers than were female patients 
(15,16). The prevalence of H. pylori infection and PUD 
can also vary by geographic location, socioeconomic sta-
tus, and age (13,17).
Although recent studies have suggested that rates of 
PUD have declined in European countries and in non-
European countries outside the United States (16,18–20), 
the overall recent national trends of PUD in the United 
States have not been described. To determine whether rates 
of hospitalization due to PUD and its complications have 
decreased and to describe the demographic characteristics 
of hospitalized persons with PUD, we conducted a retro-
spective analysis of hospital discharge data for PUD in the 
United States from 1998 through 2005.
Methods
Using the Nationwide Inpatient Sample (NIS) (21), 
we analyzed hospital discharge data during 1998–2005 
for the general US population. The NIS is the largest all-
payer, inpatient-care database in the United States; it is 
produced by the Healthcare Cost and Utilization Project 
(HCUP), sponsored by the Agency for Healthcare Re-
search and Quality in partnership with public and private 
statewide data organizations (21,22). The NIS is a strati-
ﬁ  ed probability sample of hospitals in participating states 
designed to approximate a 20% sample of all US com-
munity hospitals. Hospitals in the sampling frame include 
short-term, nonfederal general and specialty hospitals 
from as many as 37 states (in 2005). We calculated na-
tional hospitalization estimates using discharge weights 
developed by HCUP.
Diagnosis codes from the International Classiﬁ  cation 
of Diseases, 9th revision, Clinical Modiﬁ  cation  (ICD-9
-CM), were used to deﬁ  ne PUD in the following terms: 
peptic ulcer (533), gastric ulcer (531), gastrojejunal ulcer 
(534), and duodenal ulcer (532) (23). Since the ﬁ  rst-listed 
diagnosis is the condition chieﬂ  y responsible for the hos-
pitalization, hospitalizations in which 1 of these codes was 
listed as the ﬁ  rst diagnosis were considered to be more 
speciﬁ  c than hospitalizations in which 1 of these codes 
was listed as 1 of as many as 15 diagnoses. We limited the 
analysis to rates of hospitalization for ﬁ  rst-listed PUD di-
agnoses, unless otherwise stated. In a separate analysis, we 
selected records with H. pylori infection as 1 of as many as 
15 diagnoses (ICD-9-CM code 041.86), without regard to 
PUD on the record.
The PUD and H. pylori hospitalizations were exam-
ined by age group (<20, 20–44, 45–64, and >65 years 
of age), sex, race/ethnicity (white, black, Hispanic, and 
Asian or Paciﬁ  c Islander), geographic region (Northeast, 
Midwest, South, and West), designated ulcer type (peptic, 
gastric, gastrojejunal, and duodenal), other diagnoses list-
ed along a PUD diagnosis, and procedures. Race/ethnicity 
was missing in the record for 26.0% of hospitalizations.
We selected ﬁ  rst-listed hospitalizations for gastritis/
duodenitis (ICD-9-CM code 535) as a comparison group 
to ensure that a change in the PUD hospitalization rate was 
not attributable to changes in diagnoses resulting from the 
increased speciﬁ  city associated with endoscopy. Hospital-
izations for all diagnoses were also examined as a com-
parison group to ensure that a change in hospitalizations 
for PUD was not merely a reﬂ  ection of a change in the total 
number of hospitalizations for all diagnoses.
Annual average hospitalization rates were expressed as 
the number of hospitalizations per 100,000 population. The 
hospitalization rates were calculated by using the weighted 
number of hospitalizations and the census population for 
each year of the study period from HCUP (24,25). SEs 
for the hospitalization estimates were calculated by using 
SUDAAN software and discharge weights provided by 
HCUP to account for the sampling design; SEs were used 
to calculate 95% conﬁ  dence intervals (CIs) for the rates 
(25). If the relative SE of national estimates exceeded 0.30, 
or if the number of unweighted outpatient visits or hospital-
izations in a strata was <30, the estimates were considered 
unreliable and were not shown here (26).
A weighted least-squares technique was used to as-
sess a linear trend in the annual hospitalization rate for 
ulcer types during the 8-year study period of 1998–2005; 
the independent variable was year and the dependent vari-
able was the rate. A modiﬁ  cation to the classical regression 
technique was necessary to account for the changing NIS 
survey design over the study period, as described by Gil-
lum et al. (27). In this method, a regression line is ﬁ  t to the 
data, and the resulting slope is tested for difference from 
zero by using a Wald test for signiﬁ  cance; autocorrelation 
was not assessed. A p value <0.05 was considered signiﬁ  -
cant in this study.
Age-adjusted rates were calculated by using the direct 
method, taking into account the survey design, and using 
the projected 2000 US Census population as the reference 
population (28). In the direct method, the age-adjusted rate 
represents what the rate would be if the study population 
had the same age distribution as a reference population 
(i.e., the projected US Census 2000 age distribution). This 
method is used to remove confounding by age when rates 
are compared over time or across populations with differ-
ent age distributions. To calculate age-adjusted rates, the 
age group–speciﬁ  c rates (hospitalizations/population) were 
multiplied by weights representing the proportion of the 
reference population belonging in the corresponding age 
group; the resulting quantities were summed to obtain the 
age-adjusted rate (28). We report the age-adjusted PUD 
hospitalization rates; the overall age-adjusted rate did not 
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differ from the unadjusted rate, although the rates for some 
groups did differ.
Results
Overall PUD Hospitalization Rates 
A total of 1,453,892 ﬁ  rst-listed PUD hospitalizations 
were estimated for 1998–2005, with an average annual age-
adjusted hospitalization rate of 63.6/100,000 population 
(95% CI 62.9–64.3) (Table 1). The hospitalization rate was 
highest for adults >65 years of age (299.8/100,000 popu-
lation) and decreased with decreasing age group. Overall, 
age-adjusted hospitalization rates were signiﬁ  cantly higher 
for male patients than for female patients (71.9/100,000 
population [95% CI 71.0–72.7] and 56.3/100,000 popula-
tion [95% CI 55.6–57.0], respectively). The rates were sig-
niﬁ  cantly higher for male patients of all age groups and of 
all race/ethnicity groups.
Overall, age-adjusted hospitalization rates were signif-
icantly lower for whites (44.2/100,000 population; 95% CI 
43.3–45.0) than for each of the other racial/ethnic groups 
(Table 1). This rate difference for male patients was simi-
lar across groups of various races and ethnicities. Among 
female patients, the rate was signiﬁ  cantly higher for blacks 
than those for each of the other racial/ethnic groups.
The average annual age-adjusted hospitalization rate 
was higher for patients with ulcers designated gastric 
(33.7/100,000 population; 95% CI 33.3–34.2) than for 
all patients with other ulcer designations (Table 1). How-
ever, a gender-speciﬁ  c comparison showed that for male 
patients, the hospitalization rate for ulcers designated 
gastric was comparable to that for ulcers designated duo-
denal (33.5/100,000 population [95% CI 33.1–34.0] and 
33.1/100,000 population [95% CI 32.9–33.5]). Among 
female patients, the hospitalization rate for ulcers desig-
nated gastric (33.6/100,000 population; 95% CI 33.1–34.0) 
was almost double that for ulcers designated duodenal 
(17.1/100,000 population; 95% CI 16.8–17.4).
Trends over Time in PUD Hospitalization Rates 
The overall age-adjusted hospitalization rate for PUD 
decreased 21%, from 71.1/100,000 population (95% CI 
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Table 1. Number of hospitalizations and age-adjusted and age-specific rates of hospitalization for first-listed discharge diagnoses of 
peptic ulcer disease, overall and by sex, United States, 1998–2005* 
Characteristic
Male patients  Female patients  Overall
No. (SE)  Rate† (95% CI)  No. (SE)  Rate† (95% CI)  No. (SE)  Rate† (95% CI) 
Age, y
 <20  7,851
(320) 
2.4 (2.2–2.6)  4,926
(349) 
1.6 (1.4–1.8)  12,803
(602) 
2.0 (1.8–2.2) 
 20–44  113,742
(1,344) 
27.0 (26.4–27.6)  72,638
(945) 
17.5 (17.1–18.0)  186,557
(1,979) 
22.3 (21.8–22.8) 
 45–64  236,381
(2,206) 
92.6 (90.9–94.3)  165,013
(1,628) 
61.3 (60.2–62.5)  401,581
(3,480) 
76.6 (75.3–77.9) 
 >65 380,016
(3,555) 
322.5 (316.6–328.4)  472,590
(4,224) 
283.6 (278.6–288.6)  852,720
(7,409) 
299.8 (294.7–304.9)
Race/ethnicity‡
 White  392,199
(5,508) 
48.7 (47.7–49.6)  408,120
(5,712) 
40.4 (39.5–41.2)  800,358
(10,974) 
44.2 (43.3–45.0) 
 Black  70,453
(1,968) 
69.7 (67.1–72.3)  59,045
(1,733) 
46.4 (44.5–48.2)  129,499
(3,577) 
56.8 (54.7–58.8) 
 Hispanic  48,076
(1,661) 
58.4 (55.1–61.7)  33,179
(1,324) 
38.7 (36.1–41.2)  81,270
(2,887) 
48.0 (45.3–50.8) 
 Asian/Pacific  Islander  23,268
(1,158) 
68.2 (63.0–73.5)  14,789
(767) 
38.1 (34.7–41.6)  38,056
(1,846) 
51.8 (47.8–55.8) 
Ulcer type 
 Gastric  343,079
(3,011) 
33.5 (33.1–34.0)  427,469
(3,750) 
33.6 (33.1–34.0)  770,785
(6,347) 
33.7 (33.3–34.2) 
 Peptic  40,009
(678) 
3.8 (3.7–3.9)  51,452
(818) 
4.1 (4.0–4.2)  91,524
(1,313) 
4.0 (3.9–4.1) 
 Duodenal  340,161
2,973 
33.1 (32.9–33.5)  217,946
(2,055) 
17.1 (16.8–17.4)  558,443
(4,676) 
24.4 (24.1–24.7) 
 Gastrojejunal  14,772
(335) 
1.4 (1.4–1.5)  18,336
(504) 
1.5 (1.4–1.6)  33,142
(699) 
1.4 (1.4–1.5) 
Total 738,020
(5,897) 
71.9 (71.0–72.7)  715,203
(5,824) 
56.3 (55.6–57.0)  1,453,892
(11,201) 
63.6 (62.9–64.3) 
*Diagnosis codes 531–534 from the International Classification of Diseases, 9th revision, Clinical Modification. National estimates determined by using 
the Nationwide Inpatient Sample (21).
†Per 100,000 population. 
‡Race/ethnicity was missing for 26.0% of hospitalized patients. Data were insufficient for the race/ethnicity category of American Indian/Alaska Native. Hospitalizations for Peptic Ulcer Disease
68.9–73.4) in 1998 to 56.5/100,000 population (95% CI 
54.6–58.3) in 2005 (Table 2; Figure 1). The hospitaliza-
tion rate appeared to decline for all age groups (19%–22%), 
except children <20 years of age, for whom no signiﬁ  cant 
change occurred during the study period. Although the 
hospitalization rate was higher for male patients than for 
female patients in 1998 (83.1/100,000 and 60.8/100,000 
population, respectively) and in 2005 (62.2/100,000 and 
51.3/100,000 population, respectively), the difference de-
creased because of a greater decline for male patients (25%) 
than for female patients (16%). The hospitalization rate was 
signiﬁ  cantly lower in 2005 than in 1998 for all racial/eth-
nic groups, except for Hispanics; the greatest decline was 
found for blacks (40%) and the least decline was observed 
for whites (22%). The hospitalization rate was also signiﬁ  -
cantly lower in 2005 than in 1998 in all regions.
The age-adjusted rate for hospitalizations for gastritis/
duodenitis (selected as a comparison group to ensure that a 
change in the PUD hospitalization rate was not attributable 
to changes in diagnosis coding practices) decreased 16%, 
from 55.0/100,000 population (95% CI 52.6–57.4) in 1998 
to 46.0/100,000 population (95% CI 44.4–47.7) in 2005. 
The rate of hospitalization for all diagnoses (included as 
a comparison group to ensure that a change in hospitaliza-
tions for PUD was not merely a reﬂ  ection of a change in the 
total number of hospitalizations for all diagnoses) did not 
change signiﬁ  cantly during the study period.
Procedures and Other Listed Diagnoses 
Esophago-gastroduodenoscopy (EGD) with closed bi-
opsy of ≥1 sites involving the esophagus, stomach, or duode-
num was the most common procedure performed in patients 
with PUD listed as ﬁ  rst reason for hospitalization (Figure 2). 
Transfusion of packed red blood cells, endoscopic control of 
gastric or duodenal bleeding and ﬂ  exible ﬁ  beroptic colonos-
copy were also common. Many diagnoses frequently were 
listed with PUD hospitalizations. Among these, unspeciﬁ  ed 
essential hypertension, acute posthemorrhagic anemia, iron 
deﬁ  ciency anemia secondary to blood loss, diaphragmatic 
hernia, and H. pylori infection were the most common (Fig-
ure 3). A greater proportion of ulcers designated duodenal 
were listed with an H. pylori co-diagnosis than any other ul-
cer designation considered (Figure 4).
Hospitalization Rates for H. pylori Infections 
The overall age-adjusted rate of hospitalization that 
included any discharge diagnosis of H. pylori infection 
decreased 47%, from 35.9/100,000 population (95% CI 
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Table 2. Number of hospitalizations and the age-adjusted and age-specific hospitalization rates for first-listed discharge diagnoses of 
peptic ulcer disease, United States, 1998–2005* 
Characteristic 
1998 
 
2005  % Rate 
change  ȕ-coefficient‡  No. (SE)  Rate† (95% CI)  No. (SE)  Rate† (95% CI) 
Age, y               
  <20  1,524 (133)  1.9 (1.6–2.2)    1,924 (290)  2.4 (1.7–3.0)  +26  0.016§ 
  20–44  26,420 (817)  25.5 (23.9–27.0)    21,523 (656)  20.5 (19.3–21.7)  20  0.648¶ 
  45–64  50,446 (1,164)  86.6 (82.7–90.5)    50,993 (1,326)  70.0 (66.4–73.6)  19  1.911¶ 
t 65  115,181 (2,750)  332.7 (317.1–348.3)    95,349 (2,449)  259.2 (246.1–272.2)  22  8.759¶ 
Sex             
  M  100,721 (2,159)  83.1 (80.4–85.6)    84,883 (2,013)  62.2 (59.9–64.4)  25  2.164¶ 
  F  92,831 (2,080)  60.8 (58.7–62.9)    84,808 (2,040)  51.3 (49.5–53.2)  16  0.886¶ 
Race/ethnicity#             
  White  111,092 (4,086)  50.3 (47.7–52.9)    91,939 (3,765)  39.5 (37.3–41.8)  22  1.696¶ 
  Black  18,188 (1,428)  68.6 (61.7–75.6)    12,794 (899)  41.4 (37.5–45.4)  40  2.093¶ 
  Hispanic  10,850 (1,310)  63.3 (50.7–75.9)    11,079 (1,034)  43.4 (37.3–49.6)  31  0.308§ 
  Asian/Pacific Islander  4,526 (673)  59.7 (45.4–73.9)    4,220 (520)  38.2 (30.9–45.4)  36  1.620** 
Region             
  Northeast  33,578 (1,746)  60.1 (55.5–64.7)    29,046 (1,740)  49.3 (45.1–53.6)  18  1.697¶ 
  Midwest  44,910 (1,909)  70.1 (65.5–74.7)    39,097 (1,562)  57.5 (53.8–61.1)  18  0.964** 
  South  76,773 (2,551)  79.5 (75.6–83.4)    66,969 (2,711)  61.3 (57.8–64.8)  23  2.046¶ 
  West  38,315 (1,707)  68.9 (64.2–73.7)    34,746 (1,519)  53.8 (50.2–57.3)  22  1.129†† 
Total  193,576 (4,014)  71.1 (68.9–73.4)    169,858 (3,889) 56.5 (54.6–58.3)  21  1.501¶ 
*Diagnosis codes 531–534 from the International Classification of Diseases, 9th revision, Clinical Modification. National estimates were determined by 
using the Nationwide Inpatient Sample (21). 
†Per 100,000 population. 
‡E-coefficient from linear regression analysis, using a weighted least-squares technique, of the annual rate over the years of the study period. The p value 
corresponds to the test of the null hypothesis that the coefficient for year is zero. 
§ p>0.05. 
¶p<0.001. 
#Race/ethnicity was missing for 26.0% of the hospitalizations. Data were insufficient for the race/ethnicity category American Indian/Alaska Native. 
**0.01<p<0.05. 
††0.001<p<0.01. RESEARCH
34.3–37.5) in 1998 to 19.2/100,000 population (95% CI 
18.3–20.1) in 2005 (Table 3). The hospitalization rate in-
creased with age and declined during 1998–2005 for all age 
groups except children <20 years of age. The greatest per-
centage rate decrease was observed for adults >65 years of 
age, for whom the hospitalization rate decreased 54%, from 
163.5/100,000 population (95% CI 152.9–174.0) in 1998 to 
75.4/100,000 population (95% CI 70.0–80.8) in 2005. The 
hospitalization rate for male patients was only slightly high-
er than that for female patients, and the decline in rates was 
similar for both groups. In 1998, the hospitalization rate was 
higher for blacks (44.1/100,000 population; 95% CI 39.7–
48.6) and Hispanics (41.8/100,000 population; 95% CI 
34.0–49.6) than for whites (23.2/100,000 population; 95% 
CI. 21.7–27.9) and Asian/Paciﬁ  c Islanders (34.0/100,000 
population; 95% CI 26.2–41.9). In 2005, the same pattern 
was observed; hospitalization rate was signiﬁ  cantly higher 
for blacks (23.6/100,000 population; 95% CI 21.1–26.1) and 
Hispanics (24.5/100,000 population; 95% CI 21.1–27.9) 
than for whites (10.3/100,000 population; 95% CI 9.6–11.0) 
and Asian/Paciﬁ  c Islanders (15.8/100,000 population; 95% 
CI 12.0–19.6). Rates declined signiﬁ  cantly for all racial/
ethnic groups, except for Hispanics; the greatest percentage 
rate decrease was observed for whites (56%). The hospital-
ization rates were signiﬁ  cantly different in 1998 and 2005 in 
all geographic regions. In 1998, the hospitalization rate was 
higher in the South (39.3/100,000 population; 95% CI 36.4–
42.1) than in the West and Northeast regions (33.6/100,000 
and 31.4/100,000 population, respectively; 95% CI 30.8–
36.3 and 27.8–35.1, respectively). By 2005, the hospitaliza-
tion rate was higher in the South (21.6/100,000 population; 
95% CI 19.8–23.4) and in the Northeast (19.3/100,000 pop-
ulation; 95% CI. 17.6–21.0) than in the West (16.5/100,000 
population; 95% CI 14.8–18.1) because the decline appar-
ently occurred more slowly in the Northeast (39%) than in 
all other regions.
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Figure 1. Age-adjusted hospitalization rates for ﬁ  rst-listed discharge diagnoses of peptic ulcer disease (diagnosis codes 531–534 from 
the International Classiﬁ   cation of Diseases, 9th revision, Clinical Modiﬁ   cation), United States, 1998–2005. A) Overall age-adjusted 
hospitalization rate. B) Age-adjusted hospitalization rate by gender. C) Age-adjusted hospitalization rate by race/ethnicity. D) Age-
adjusted hospitalization rate by region. Source: Nationwide Inpatient Sample (21). Race/ethnicity information was missing for 26.0% of 
hospitalizations.Hospitalizations for Peptic Ulcer Disease
Discussion
Our analysis of hospital discharge records from a na-
tionally representative sample of US hospitals indicates that 
the overall age-adjusted rate of hospitalization for PUD de-
clined during 1998–2005. This ﬁ  nding is consistent with 
decreases previously observed for PUD hospitalizations in 
the United States in several studies from the 1970s through 
the 1990s (7,8,14,17,29). One study by Manuel et al. did 
not observe a downward trend in PUD hospitalizations dur-
ing 1996–2005; however, that study included only 5 hospi-
tals (30). We analyzed data for ﬁ  rst-listed PUD hospitaliza-
tions to limit data to hospitalizations for care speciﬁ  cally 
for ulcer-related issues. In addition, >50% of patients in our 
study had an EGD with closed biopsy of ≥1 sites involv-
ing the esophagus, stomach, or duodenum (Figure 2). EGD 
with biopsy is a reliable technique to differentiate between 
PUD and other causes of abdominal pain such as gastritis 
(17). Thus, it appears that the data in this study are reﬂ  ec-
tive of patients who were truly hospitalized primarily for 
PUD or its complications.
Decreases in PUD hospitalizations are likely attrib-
utable to an underlying decline in H. pylori prevalence 
(7,15). However, declines in PUD hospitalizations have 
also been attributed to changes in diagnosis coding because 
of improved diagnostic speciﬁ  city associated with endos-
copy (31). If the decrease in PUD hospitalizations was at-
tributable to changes in diagnosis coding, the decrease in 
PUD hospitalizations would be inversely related to a rise 
in hospitalizations for gastritis/duodenitis. We found that 
hospitalization rates declined for gastritis/duodenitis and 
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Figure 2. Hospital procedures most frequently listed with ﬁ  rst-listed 
discharge diagnoses of peptic ulcer disease (diagnosis codes 
531–534 from the International Classiﬁ   cation of Diseases, 9th 
revision, Clinical Modiﬁ  cation [ICD-9-CM]), United States, 1998–
2005. Source: Nationwide Inpatient Sample (21). EGD, esophago-
gastroduodenoscopy. 
Table 3. Number of hospitalizations and the age-adjusted and age-specific hospitalization rates for any-listed discharge diagnoses that 
included Helicobacter pylori infection, United States, 1998–2005* 
Characteristic
1998 2005  % Rate 
change ȕ-coefficient‡ No. (SE)  Rate† (95% CI)  No. (SE)  Rate† (95% CI) 
Age, y  
  <20  1,320 (151)  1.7 (1.3–2.0)  1,718 (276)  2.1 (1.4–2.8)  +24 0.040§ 
  20–44  14,617 (648)  14.1 (12.9–15.3)  10,391 (457)  9.9 (9.0–10.7)  30 0.436¶
  45–64  25,287 (955)  43.4 (40.2–46.6)  17,923 (724)  24.6 (22.7–26.6)  43 2.265¶
 >65 56,593 (1,866)  163.5 (152.9–174.0)  27,733 (1,009)  75.4 (70.0–80.8)  54 10.647¶ 
Sex
  M  47,162 (1,450)  38.9 (37.2–40.6)  28,535 (946)  20.6 (19.6–21.6)  47 1.854¶
  F  50,656 (1,830)  33.4 (31.7–35.0)  29,220 (1,078)  18.0 (17.0–18.9)  46 1.909¶
Race/ethnicity# 
  White  51,235 (2,353)  23.2 (21.7–24.7)  23,735 (1,117)  10.3 (9.6–11.0)  56 1.649¶
  Black  11,724 (887)  44.1 (39.7–48.6)  7,480 (561)  23.6 (21.1–26.1)  47 1.926¶
  Hispanic  7,305 (839)  41.8 (34.0–49.6)  7,075 (720)  24.5 (21.1–27.9)  41 0.131§ 
  Asian/Pacific Islander  2,563 (361)  34.0 (26.2–41.9)  1,771 (252)  15.8 (12.0–19.6)  54 1.471¶
Region 
  Northeast  17,551 (1,588)  31.4 (27.8–35.1)  11,285 (681)  19.3 (17.6–21.0)  39 1.392¶
  Midwest  23,644 (1,430)  36.9 (33.6–40.2)  12,116 (722)  17.9 (16.3–19.5)  52 2.229¶
  South  37,929 (2,100)  39.3 (36.4–42.1)  23,603 (1,476)  21.6 (19.8–23.4)  45 2.193¶
  West  18,699 (1,038)  33.6 (30.8–36.3)  10,766 (738)  16.5 (14.8–18.1)  51 1.493¶
Total 97,823 (3,156)  35.9 (34.3–37.5)  57,770 (1,925)  19.2 (18.3–20.1)  47 1.884¶
*Diagnosis codes 41.86 from the International Classification of Diseases, 9th revision, Clinical Modification. National estimates were determined by using 
the Nationwide Inpatient Sample (21). All H. pylori diagnoses are 1 of as many as 15 diagnoses.  
†Per 100,000 population. 
‡E-coefficient from linear regression analysis, using a weighted least-squares technique, of the annual rate over the years of the study period. The p value 
corresponds to the test of the null hypothesis that the coefficient for year is zero. 
§pt0.05. 
¶p<0.001. 
#Race/ethnicity was missing for 26.0% of the patients hospitalized. Data were insufficient for the race/ethnicity category American Indian/Alaska Native. RESEARCH
for PUD, which indicates that the results cannot be attribut-
able to changes in diagnosis coding practices. Furthermore, 
because the hospitalization rate for all diagnoses did not 
change signiﬁ  cantly from 1998 to 2005, the decline in the 
PUD hospitalization rate observed would not merely reﬂ  ect 
general trends in hospitalization. The overall rate for any 
listed H. pylori diagnosis declined signiﬁ  cantly during the 
study period, which suggests that a decrease in rates of H. 
pylori infections may be partially responsible for the de-
crease in hospitalizations for PUD.
In our study, the overall rate of hospitalizations for PUD 
differed according to the patient’s age, sex, race/ethnicity, 
and region. The highest rates of hospitalization for those with 
both PUD and H. pylori infection were for adults >65 years 
of age and decreased with each subsequent age group. This 
ﬁ  nding may result from an underlying birth cohort effect, in 
this case a decrease in H. pylori incidence for younger gener-
ations because of improved sanitation and fewer risk factors 
for transmission (18,32,33). A similar percentage change in 
rate of PUD hospitalizations was observed for all age groups 
>20 years. The comparable declines for these age groups 
may be partially attributable to increased use of H. pylori 
eradication therapy during 1998–2005, perhaps because of 
increased awareness among clinicians and patients of the as-
sociation between H. pylori and PUD (9).
In this study, the overall rate of hospitalization for 
PUD in 1998 was higher for male patients than for female 
patients. However, by 2005 this difference had narrowed 
considerably because of a greater decrease in for male pa-
tients than for female patients. A 1985 study that examined 
data from the National Center for Health Statistics also 
recognized a trend toward comparable rates of hospitaliza-
tion for both sexes (34). Our study also found differences 
in hospitalization rates between sexes by designated ulcer 
type; duodenal ulcer hospitalization rates were higher for 
male patients than for female patients. This ﬁ  nding is con-
sistent with hospital admission data from the United King-
dom (15,16).
A study that used a national sample of US hospital dis-
charge records noted differences in the hospitalization rate 
for PUD between racial/ethnic groups; blacks were more 
frequently hospitalized for PUD than whites in 1998 (13). 
Although we also found that rate of hospitalization for PUD 
was higher for blacks than for whites, the rate appears to be 
declining more rapidly for blacks than for whites. In addi-
tion, although rates were signiﬁ  cantly lower for whites than 
for those in other racial/ethnic categories in 1998, by 2005 
this rate difference was no longer signiﬁ  cant because for 
whites, the decline apparently occurred more slowly than it 
did for all other racial/ethnic groups. Differences also varied 
by sex, as well as race/ethnicity, and suggest that hospital-
izations for PUD among nonwhite men may merit further 
investigation. Race/ethnicity information was missing for 
patients in 26% of hospitalization records, possibly mak-
ing comparisons between racial/ethnic groups inaccurate. A 
study of underreporting of race/ethnicity information in the 
National Hospital Discharge Survey suggests that hospitals 
that do not report race/ethnicity information may have a 
higher proportion of discharges for whites and a lower pro-
portion of discharges for blacks than hospitals that do report 
race/ethnicity information (35). Our study did not examine 
PUD hospitalizations for American Indians and Alaska Na-
tives because the survey’s sample size was not large enough 
and did not include visits to Indian Health Service or tribal 
facilities. However, a previous study showed that among 
American Indians and Alaska Natives, the prevalence of 
ulcer-associated conditions was high during 1996–2005, 
which indicates that hospitalizations for PUD among this 
group may warrant further study (36).
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Figure 3. Other diagnoses most frequently listed with ﬁ  rst-listed 
discharge diagnoses of peptic ulcer disease (PUD) (diagnosis 
codes 531–534 from the International Classiﬁ  cation of Diseases, 
9th revision, Clinical Modiﬁ  cation [ICD-9-CM]), United States, 1998–
2005. Source: Nationwide Inpatient Sample (21). Iron deﬁ  ciency 
anemias, iron deﬁ  ciency anemias secondary to blood loss. 
Figure 4. Proportion of ﬁ   rst-listed ulcer diagnoses with a co-
diagnosis of Helicobacter pylori infection (diagnosis codes 531–
534 from the International Classiﬁ  cation of Diseases, 9th revision, 
Clinical Modiﬁ   cation [ICD-9-CM]), by ulcer type, United States, 
1998–2005. Source: Nationwide Inpatient Sample (21). PUD, 
peptic ulcer disease.Hospitalizations for Peptic Ulcer Disease
Our study showed similar trends for hospitalizations 
for PUD and H. pylori infection, although we noted some 
differences. For both PUD and H. pylori infections, the rate 
of hospitalization increased with age, and the age-adjusted 
hospitalization rate was lower for whites than for persons 
in any other racial/ethnic group category. In addition, the 
overall age-adjusted rate of both PUD and H. pylori hos-
pitalizations was higher for male patients than for female 
patients. However, although the age-adjusted PUD hospi-
talization rate appears to be declining more rapidly among 
male patients than among female patients, the age-adjusted 
H. pylori infection hospitalization rate appears to be declin-
ing at a similar pace for female patients and male patients. 
The age-adjusted PUD hospitalization rate for Hispanics 
did not decline signiﬁ  cantly, and a decline in the age-ad-
justed H. pylori hospitalization rate for this group was only 
borderline signiﬁ  cant, which suggests that rates among this 
group may deserve special attention. However, this ﬁ  nd-
ing may be biased because of missing information on race/
ethnicity.
Our ﬁ  ndings in this study show a continued down-
ward trend in the rate of hospitalizations for PUD in the 
United States. Differences in the rate of decline for PUD 
hospitalization rates between sexes, racial/ethnic groups, 
and regions warrant further study. The overall downward 
trend observed in this study does not seem to be attribut-
able to increases in gastritis/duodenitis hospitalizations 
or to a decline in total hospitalizations. The decline in the 
PUD hospitalization rate may be attributable to a birth co-
hort effect with subsequent declines in H. pylori infection 
prevalence and increased use of successful antibiotic treat-
ments to eradicate H. pylori infections. Other factors pos-
sibly contributed to the decline in PUD hospitalizations ob-
served in this study, including trends in use of nonsteroidal 
anti-inﬂ  ammatory drugs and the availability of over-the-
counter H2 antagonists and proton pump inhibitors. Stud-
ies on the relationship between PUD hospitalizations and 
nonsteroidal anti-inﬂ  ammatory drug use, the possibility of 
undercoding for H. pylori on hospitalization discharge re-
cords, and subpopulation analyses would help further guide 
recommendations and show how to focus interventions. To 
facilitate further declines in hospitalizations for PUD, pa-
tients and clinicians should continue to be educated about 
the association between H. pylori and PUD. 
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etymologia etymologia
Klebsiella
[kleb  se-el′ə]
The genus Klebsiella, family Enterobacteriaceae, was named by V. Trevisan in 1885 in honor of German 
bacteriologist Theodor Albrecht Edwin Klebs (1834–1913). Dr Klebs is known for his pioneering work 
demonstrating that microorganisms are responsible for infectious diseases. He also studied the pathologic and 
bacteriologic features of gunshot wounds; investigated tuberculosis and successfully transmitted the disease 
to cattle; did research on the bacteriologic characteristics of malaria and anthrax; and, with Friedrich A.J. 
Löfﬂ  er in 1884, discovered the etiologic agent of diphtheria, ﬁ  rst called the Klebs-Löfﬂ  er bacillus (later called 
Corynebacterium diphtheriae).
Source:  Dworkin M, Falkow S, Rosenberg E, Schleifer K-H, Stackebrandt E. The prokaryotes. Klebsiella. New York: Springer; 
2006. p. 159–96; Carter KC. Koch’s postulates in relation to the work of Jacob Henle and Edwin Klebs. Medical History. 
1985;29:353–74; Dorland’s illustrated medical dictionary, 31st edition. Philadelphia: Saunders Elsevier; 2007. 